Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TAM”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00489944
What this trial is testing

Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma

Who this might be right for
Intraocular Melanoma
San Diego Pacific Oncology & Hematology Associates 50
Large-scale testing (Phase 3)Study completedNCT00949598
What this trial is testing

Letrozole or Tamoxifen Citrate in Treating Older Postmenopausal Women Undergoing Surgery for Breast Cancer

Who this might be right for
Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 177
Large-scale testing (Phase 3)UnknownNCT01579734
What this trial is testing

Phase III, Randomized, Double Blind Trial Low Dose Tamoxifen Versus Placebo in Hormone Replacement Therapy (HRT) Users

Who this might be right for
Breast Cancer
European Institute of Oncology 1,884
Not applicableUnknownNCT05717634
What this trial is testing

Endometrial Changes in Breast Cancer Women.

Who this might be right for
Endometrial CancerEndometrial Hyperplasia With AtypiaBreast Cancer+1 more
Regina Elena Cancer Institute 829
Large-scale testing (Phase 3)Looking for participantsNCT05774951
What this trial is testing

Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

Who this might be right for
Breast Cancer, Early Breast Cancer
AstraZeneca 4,300
Not applicableStudy completedNCT01223833
What this trial is testing

A Prospective Assessment of Loss of Grip Strength by Baseline BMI in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitors and Tamoxifen

Who this might be right for
Breast CancerArthralgia
Universitaire Ziekenhuizen KU Leuven 296
Very early researchStudy completedNCT02913430
What this trial is testing

Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib

Who this might be right for
Metastatic Breast Cancer
Shannon Puhalla 7
Early research (Phase 1)Study completedNCT00005886
What this trial is testing

Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
University of Kansas Medical Center
Post-approval studies (Phase 4)Study completedNCT01189500
What this trial is testing

Open-Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Tamoxifen When Coadministered To Healthy Post-Menopausal Female Subjects

Who this might be right for
Pharmacokinetics
Pfizer 30
Post-approval studies (Phase 4)Study completedNCT02479256
What this trial is testing

Clomiphene Citrate Versus Tamoxifen for Ovulation Induction in PCOs

Who this might be right for
PCOS
Ain Shams University 600
Large-scale testing (Phase 3)Active Not RecruitingNCT01272037
What this trial is testing

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Who this might be right for
Breast Ductal Carcinoma In SituInvasive Breast CarcinomaMulticentric Breast Carcinoma+2 more
National Cancer Institute (NCI) 5,018
Testing effectiveness (Phase 2)Study completedNCT00290745
What this trial is testing

Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ

Who this might be right for
Breast Cancer
University of California, San Francisco 79
Post-approval studies (Phase 4)UnknownNCT02467686
What this trial is testing

Breast Cancer, Sexuality and Black Cohosh

Who this might be right for
Sexuality
Irmandade da Santa Casa de Misericordia de Sao Paulo 60
Testing effectiveness (Phase 2)UnknownNCT04568096
What this trial is testing

Combination of Chemopreventive Agents (All- Trans Retinoic Acid and Tamoxifen) as Potential Treatment for the Lung Complication of COVID-19

Who this might be right for
the Lung Complication of COVID-19
Kafrelsheikh University 160
Testing effectiveness (Phase 2)Ended earlyNCT00532454
What this trial is testing

Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen

Who this might be right for
Breast CancerMetastatic Disease
National Cancer Center, Korea 21
Post-approval studies (Phase 4)Study completedNCT02824224
What this trial is testing

Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)

Who this might be right for
MenorrhagiaMetrorrhagiaMedicated Intrauterine Devices
Oregon Health and Science University 42
Early research (Phase 1)Study completedNCT02333370
What this trial is testing

A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer

Who this might be right for
Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
Novartis Pharmaceuticals 88
Testing effectiveness (Phase 2)UnknownNCT00492687
What this trial is testing

Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
San Diego Pacific Oncology & Hematology Associates 80
Not applicableUnknownNCT04891731
What this trial is testing

Efficacy and Safety of Leuprorelin 3M in Premenopausal Women With Hormone Receptor-positive Breast Cancer

Who this might be right for
Hormone Receptor-positive Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 120
Testing effectiveness (Phase 2)Study completedNCT03680521
What this trial is testing

Neoadjuvant Sitravatinib in Combination With Nivolumab in Patients With Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
Mirati Therapeutics Inc. 25
Next Page